Best-Selling Cholesterol Drugs Found Ineffective
Submitted by Anne Landman on
Three million people worldwide are taking the new, heavily advertised anti-cholesterol drugs Zetia and Vytorin, despite a lack of clinical evidence that they reduce cardiovascular disease or heart attacks, or help patients live longer.